(3R,4S)-​Tofacitinib citirate
|
Impurities |
CS-O-39729 |
2174011-53-9 |
Enquire |
(3R,4S)-Tofacitinib
|
Impurities |
CS-T-62103 |
1092578-46-5 |
In Stock |
(3S,4R)-Tofacitinib
|
Impurities |
CS-T-62105 |
1092578-48-7 |
In Stock |
(3S,4S)-Tofacitinib
|
Impurities |
CS-T-62104 |
1092578-47-6 |
Enquire |
1,2,3,6,-tetrahydro-1- nitroso4-picoline
|
Impurities |
CS-O-45591 |
89600-66-8 |
Enquire |
2,4-Dichloro-7H-Pyrrolo (2,3-d)Pyrimidine
|
Impurities |
CS-M-42734 |
90213-66-4 |
In Stock |
3-((3R,4R)-4-methyl-3-(methyl((5R,6S)-2,5,6-trihydroxy-6,7-d...
|
Impurities |
CS-O-35885 |
2102039-98-3 |
Enquire |
3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-...
|
Impurities |
CS-O-36711 |
Not Available |
Enquire |
3H-pyrrolo[2,3-d]pyrimidin-4(5H)-one
|
Impurities |
CS-O-55715 |
1194710-85-4 |
Enquire |
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide
|
Impurities |
CS-O-45589 |
Not Available |
Enquire |
N,4-dimethyl-1-nitrosopiperidin-3-amine
|
Impurities |
CS-O-45597 |
Not Available |
Enquire |
N-Desmethyl Tofacitinib
|
Impurities |
CS-O-54946 |
1527525-58-1 |
Enquire |
N-methyl-N-(4-methyl-1-nitrosopiperidin-3-yl)nitrous amide
|
Impurities |
CS-O-45598 |
Not Available |
Enquire |
N-methyl-N-(4-methylpiperidin-3-yl)nitrous amide
|
Impurities |
CS-O-45599 |
Not Available |
Enquire |
N-methyl-N-(4-methylpyridin-3-yl)nitrous amide
|
Impurities |
CS-O-46286 |
Not Available |
Enquire |
N-Nitroso Tofacitinib Amine Impurity
|
Impurities |
CS-O-40197 |
Not Available |
In Stock |
Tofacitinib formyl impurity
|
Impurities |
CS-EO-01760 |
2227199-28-0 |
In Stock |
Tofacitinib 5 Oxo Impurity
|
Impurities |
CS-EO-01501 |
2101951-20-4 |
Enquire |
Tofacitinib Benzyl Impurity
|
Impurities |
CS-T-88424 |
477600-73-0 |
In Stock |
Tofacitinib butyl ester impurity
|
Impurities |
CS-O-43010 |
Not Available |
Enquire |
Tofacitinib Butyl Impurity
|
Impurities |
CS-O-54081 |
2716897-36-6 |
Enquire |
Tofacitinib Citrate Diasteromeric impurity
|
Impurities |
CS-O-46779 |
2664002-63-3 |
Enquire |
Tofacitinib Diastereomer
|
Impurities |
CS-EO-00128 |
344418-92-4 (Freebase) |
Enquire |
Tofacitinib Diastereomer-1 and 2
|
Impurities |
CS-O-33660 |
2734856-31-4 |
Enquire |
Tofacitinib Dihydro Citricacid salt impurity
|
Impurities |
CS-O-44098 |
1809002-40-1 |
Enquire |
Tofacitinib Dihydro Impurity
|
Impurities |
CS-T-89311 |
1640972-35-5 |
In Stock |
Tofacitinib Dimer
|
Impurities |
CS-O-57969 |
Not Available |
Enquire |
Tofacitinib Hydroxy Impurity
|
Impurities |
CS-EO-02225 |
1092578-46-5 |
Enquire |
Tofacitinib Impurity 19
|
Impurities |
CS-O-58215 |
2459302-82-8 |
Enquire |
Tofacitinib Impurity 29
|
Impurities |
CS-EO-03056 |
2459302-85-1 |
Enquire |
Tofacitinib Impurity 57
|
Impurities |
CS-EO-03055 |
2315287-12-6 |
Enquire |
Tofacitinib Impurity 59
|
Impurities |
CS-O-58346 |
32018-56-7 |
Enquire |
Tofacitinib Impurity 6
|
Impurities |
CS-EO-01450 |
2504210-38-0 |
In Stock |
Tofacitinib Impurity 67
|
Impurities |
CS-O-57488 |
2716897-35-5 |
Enquire |
Tofacitinib impurity C
|
Impurities |
CS-AQ-00034 |
Not Available |
Enquire |
Tofacitinib impurity F
|
Impurities |
CS-AQ-00036 |
Not Available |
Enquire |
Tofacitinib Impurity G
|
Impurities |
CS-AQ-00037 |
1354486-07-9 |
In Stock |
Tofacitinib impurity I
|
Impurities |
CS-AQ-00038 |
Not Available |
Enquire |
Tofacitinib impurity J
|
Impurities |
CS-AQ-00039 |
1431697-80-1 |
Enquire |
Tofacitinib impurity K
|
Impurities |
CS-AQ-00040 |
2328165-36-0 |
In Stock |
Tofacitinib Impurity L
|
Impurities |
CS-AQ-00041 |
1675248-19-7 |
In Stock |
Tofacitinib impurity N
|
Impurities |
CS-AQ-00042 |
1260614-73-0 |
Enquire |
Tofacitinib impurity P
|
Impurities |
CS-AQ-00044 |
1252883-90-1 |
Enquire |
Tofacitinib impurity T
|
Impurities |
CS-AQ-00046 |
Not Available |
Enquire |
TOFACITINIB IMPURITY TOF-IV
|
Impurities |
CS-O-49452 |
2227197-38-6 |
Enquire |
Tofacitinib impurity U
|
Impurities |
CS-AQ-00047 |
Not Available |
Enquire |
Tofacitinib impurity V
|
Impurities |
CS-AQ-00048 |
1616761-00-2 |
Enquire |
Tofacitinib impurity W
|
Impurities |
CS-AQ-00049 |
Not Available |
Enquire |
Tofacitinib impurity X
|
Impurities |
CS-AQ-00050 |
2097982-05-1 |
Enquire |
Tofacitinib impurity Z
|
Impurities |
CS-AQ-00052 |
477600-76-3 |
Enquire |
Tofacitinib- Keto Impurity
|
Impurities |
CS-DN-00028 |
Not Available |
Enquire |
Tofacitinib N- acid Impurity
|
Impurities |
CS-DN-00027 |
Not Available |
Enquire |
Tofacitinib N-Descyanoacetyl Hydrochloride Impurity
|
Impurities |
CS-O-10647 |
1260590-51-9 |
In Stock |
Tofacitinib N-hydroxy impurity
|
Impurities |
CS-EO-00807 |
Not Available |
Enquire |
Tofacitinib Nitroso Impurity 1
|
Impurities |
CS-O-45592 |
Not Available |
Enquire |
Tofacitinib Nitroso Impurity 3
|
Impurities |
CS-O-45594 |
Not Available |
Enquire |
Tofacitinib Nitroso Impurity 4
|
Impurities |
CS-O-45595 |
Not Available |
Enquire |
Tofacitinib Nitroso Impurity 5
|
Impurities |
CS-O-45596 |
Not Available |
Enquire |
Tofacitinib N-Nitroso benzyl intermediate
|
Impurities |
CS-O-47117 |
Not Available |
In Stock |
Tofacitinib N-oxide
|
Impurities |
CS-T-89823 |
2028267-73-2 |
Enquire |
Tofacitinib Related Compound 26 HCl
|
Impurities |
CS-P-02224 |
1206824-85-2 |
Enquire |
Tofacitinib Related Compound 29
|
Impurities |
CS-EO-01845 |
134965-85-8 |
Enquire |
Tofacitinib S,S Isomer
|
Impurities |
CS-O-33661 |
2174011-55-1 |
Enquire |